Influencing factors for hemolytic anemia in patients with chronic hepatitis C treated by ribavirin combined with pegylated interferon-α

Objective To investigate the influencing factors for ribavirin (RBV)-induced hemolytic anemia during the treatment of chronic hepatitis C using RBV combined with pegylated interferon-α (PEG-IFNα), and to provide a reference for early prediction of RBV-related hemolytic anemia in clinical practice. M...

Full description

Bibliographic Details
Main Author: XU Jinfeng
Format: Article
Language:zho
Published: Editorial Department of Journal of Clinical Hepatology 2019-02-01
Series:Linchuang Gandanbing Zazhi
Online Access:http://www.lcgdbzz.org/qk_content.asp?id=9595